Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Browse by All Cardiff Authors

Number of items: 3.

Macbeth, Fergus, Noble, Simon ORCID: https://orcid.org/0000-0001-5425-2383, Evans, Jessica, Ahmed, Sheikh, Cohen, David, Hood, Kerenza ORCID: https://orcid.org/0000-0002-5268-8631, Knoyle, Dana, Linnane, Seamus, Longo, Mirella ORCID: https://orcid.org/0000-0002-9867-3806, Moore, Barbara, Woll, Penella J., Appel, Wiebke, Dickson, Jeanette, Ferry, David, Brammer, Caroline and Griffiths, Gareth 2016. Randomized phase III trial of standard therapy plus low molecular weight heparin in patients with lung cancer: FRAGMATIC trial. Journal of Clinical Oncology 34 (5) , pp. 488-494. 10.1200/JCO.2015.64.0268

Noble, Simon I. ORCID: https://orcid.org/0000-0001-5425-2383, Nelson, Annmarie ORCID: https://orcid.org/0000-0002-6075-8425, Fitzmaurice, David, Bekkers, Marie-Jet, Baillie, Jessica ORCID: https://orcid.org/0000-0002-4592-7286, Sivell, Stephanie ORCID: https://orcid.org/0000-0003-0253-1860, Canham, Joanna ORCID: https://orcid.org/0000-0003-3482-0990, Smith, Joanna D. ORCID: https://orcid.org/0000-0003-4234-6686, Casbard, Angela ORCID: https://orcid.org/0000-0001-6241-3052, Cohen, Ander, Cohen, David, Evans, Jessica, Fletcher, Kate, Johnson, Miriam, Maraveyas, Anthony, Prout, Hayley ORCID: https://orcid.org/0000-0003-0170-7027 and Hood, Kerenza ORCID: https://orcid.org/0000-0002-5268-8631 2015. A feasibility study to inform the design of a randomised controlled trial to identify the most clinically effective and cost-effective length of Anticoagulation with Low-molecular-weight heparin In the treatment of Cancer-Associated Thrombosis (ALICAT). Health Technology Assessment 19 (83) , pp. 1-94. 10.3310/hta19830
file

Geldart, Thomas, Chester, John ORCID: https://orcid.org/0000-0002-7830-3840, Casbard, Angela ORCID: https://orcid.org/0000-0001-6241-3052, Crabb, Simon, Elliott, Tony, Protheroe, Andrew, Huddart, Robert A., Mead, Graham, Barber, Jim, Jones, Robert J., Smith, Joanna ORCID: https://orcid.org/0000-0003-4234-6686, Cowles, Robert, Evans, Jessica and Griffiths, Gareth 2015. SUCCINCT: an open-label, single-arm, non-randomised, phase 2 trial of gemcitabine and cisplatin chemotherapy in combination with sunitinib as first-line treatment for patients with advanced urothelial carcinoma. European Urology 67 (4) , pp. 599-602. 10.1016/j.eururo.2014.11.003
file

This list was generated on Thu Apr 18 10:19:45 2024 BST.